Clinical Trials Logo

Clinical Trial Summary

Pregnant women with pre-eclampsia and growth restricted fetuses often have a reduced function of the placenta. This is accompanied by an increased perinatal mortality and morbidity.

By ultrasound it is possible to measure blood flow and vascular resistance in both the fetal umbilical cord and in the blood vessels supplying the uterus. A high resistance in these vessels occur before the child is severely affected.

By immersion in water extracellular fluid is redistributed back into the circulation, and central blood volume increases. Previous studies have shown that maternal minute-volume increases, while blood pressure drops slightly. Also an increased amniotic fluid has been recorded. This has been interpreted as an expression of increased renal blood flow. Immersion into water could increase blood flow in the vessels supplying the uterus and thus increase blood flow to the child.

The investigators aim to clarify this by examining blood flow and resistance in the blood vessel supplying the uterus and in the umbilical cord, while the participant is immersed into water. Initially, 25 healthy women with an uncomplicated singleton pregnancy recruited from the Department of Obstetrics and Gynaecology: Hvidovre University Hospital, Denmark, will be examined. The participant will act as its own control and measurements above water and immersed will be conducted at the same study session.

Ultimately the investigators seek to contribute to a non-invasive option for prolonging those pregnancies where the fetus and/or maternal condition requires delivery several weeks before term, and where immersion of the pregnant woman in the water a few hours one to several times daily, may prolong the pregnancy the required number of hours/days for antenatal steroid treatment to be sufficient.

There are no risks associated with the study and the project team considers it ethical to implement this. The study is not supported by pharmaceutical companies or other groups with economic interests. The project group itself has taken the initiative to study.


Clinical Trial Description

Intrauterine growth retardation and preeclampsia are major causes of neonatal mortality, morbidity and later neurological sequelae. The conditions are associated with an increased resistance to blood flow in the placenta, that can be detected by an increase in pulsatility index (PI) in the umbilical artery (1).

When Doppler flow is assessed in the uterine arteries, increased resistance in the uteroplacental circuit is indicated both by an increase in PI and by a change in the flow velocity waveform, which can be seen as a "notch" in early diastole.

In the 2nd trimester, the invasion of trophoblasts and the remodeling of the uterine spiral arteries are complete. Persistence of a bilateral notch beyond the 24th week of gestation is associated with an increased risk of intrauterine growth retardation and preeclampsia. Even though the risk persists, the notch usually disappears later in pregnancy (2).

When the non-pregnant body is immersed in water, extracellular fluid is redistributed back into the circulation. Central blood volume, cardiac output, renal perfusion and urine output increase and the blood pressure falls (3-7).

The same changes occur in the pregnant women. However the increased diuresis is strongly correlated with the degree of the pregnancy edema, which decreases substantially (8), and the amount of amniotic fluid increases (9). The changes all occur within minutes (8), but are transient and return to conditions before immersion within 1-2 hours after the pregnant woman has come out of the water.

The changes in the above parameters are significant but less pronounced in pregnant women with preeclampsia than in pregnant women without the condition (11). None of the experiments showed changes in the fetal heart rate.

Because of the physiological changes that take place when pregnant women are immersed in water, several authors have speculated whether immersion has a positive effect on the uteroplacental circuit (8,10,12).

There are no published data on Doppler flow measurements in the umbilical artery and the uterine arteries during water immersion.

The aim of the present study is to evaluate the effect of immersion on the fetoplacental and uteroplacental circuits in healthy pregnant women, using Doppler flow measurements in the umbilical artery and uterine arteries.

Materials From the Department of Obstetrics and Gynecology, Hvidovre University Hospital, Denmark, we recruit 25 healthy women with an uncomplicated singleton pregnancy. Gestational age was between 26 and 38 weeks. All participants will have a normal first trimester combined screening and a normal second trimester ultrasound scan for fetal abnormalities. Within the last 2 weeks prior to participation, fetal weight will be estimated, and only woman with fetuses of normal weight (within the 95 percentile) will be included.

Methods The study is performed at the labor ward at Hvidovre Hospital, Denmark. If fetal weight has not been estimated by an ultrasound examination within the last 2 weeks, fetal weight will be estimated on the day of the study. In order to exclude an on-going infection, the temperature is measured and the urine examined in all participants on the day of the study.

The same experienced sonographer performs all examinations, and the same Bruel & Kjaer ultrasound scanner, suitable for scanning under water, is used in all participants.

Each participant has five recordings of blood pressure, pulse, saturation, deepest vertical pocket (DVP) of amniotic fluid and Doppler flow in the umbilical artery and uterine arteries. All recordings are obtained during the same study session. Doppler ultrasound measurements of umbilical and uterine arteries are obtained by pulsed wave ultrasound using an insonating angle as close to 0 degrees as possible. The Doppler measurements on the uterine arteries are obtained approximately one centimeter from the crossing of the iliac arteries. The pulsatility index (PI) is calculated automatically by the machine using the formula (systolic velocity-diastolic velocity)/mean velocity. PI of the uterine artery is calculated as the mean PI of the left and the right uterine artery.

For immersion, a regular bathtub is used. The tub is filled with thermo-neutral tap water (35.0 °C +/- 0.5 °C). The temperature of the water is measured every 10 minutes, and kept thermo-neutral during the period of immersion.

The participants are placed in a supine position outside the bathtub and the first recordings are obtained (T0). Afterwards the participants are immersed in water, placed in a supine position, and measurements are repeated after 5 min (T5) and 25 min (T25) in water. All measurements are repeated with the participant in a supine position outside the bathtub 15 min (T40) and 30 min (T55) after immersion.

All recordings of Doppler flow curves and measurements of amniotic fluid (DVP) are saved on an USB stick. An experienced specialist in fetal medicine, who is not present at the investigation, validates each recording blindly. Any recording not eligible for approval is redefined as a missing value.

Statistical analysis Because the measurements taken before, during and after immersion, are made in the same patient during the same study session, and with the same ultrasound apparatus, each participant act as their own control.

Data are expressed as means +/- standard error of the mean (SEM). The first recording, T0, was defined as baseline. Comparisons between the respective recordings, T0-T55, are done using a two-tailed paired t-test on raw data. P-values < 0.05 are considered significant. For calculation, STATA 12.1 (13) is used. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01799343
Study type Interventional
Source Hvidovre University Hospital
Contact
Status Completed
Phase N/A
Start date February 2011
Completion date March 2012

See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02566005 - A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor N/A